TEE-guided cardioversion with short-term anticoagulation may be effective for people with atrial fibrillation undergoing electrical cardioversion.

摘要

People with atrial fibrillation are conventionally treated with therapeutic anticoagulation for three weeks before and four weeks after cardioversion to reduce the risk of thromboembolism. Using transe-sophageal echocardiography to guide short-term anticoagulation has been proposed as an alternative.